Gene Query: FAN1

Dataset Description Geneva Score
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 29.73
Control of prostate tumour growth by the long non-coding RNA GHSROS 25.93
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 19.2
Triple vectors expand AAV transfer capacity in the retina 18.06
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 13.03
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 12.32
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 11.17
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 11.01
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 10.53
RNA-seq in transgenic cells 10.22
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 9.91
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 9.68
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 9.6
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 9.49
RNAseq analysis of ESRP regulated splicing events in prostate cancer 9.27
Paxillin regulates genomic networks in prostate cancer [LNCaP] 9.22
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 9.21
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 9.15
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 9.11
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 9.11
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 8.74
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 8.51
Biological effect of chronic mistranslation in mammalian cells 8.29
MYCL and EP400 are required for Max and MCPyV mediated gene activation 8.22
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 8.17
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 8.09
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.94
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.94
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 7.9
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 7.87
Global transcriptome analysis of HAP1 cells 7.75
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 7.6
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.57
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.38
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 7.34
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 7.24
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 7.22
Genome-wide analysis of the Integrator complex (HTS) 7.08
Genome-wide analysis of the Integrator complex 7.08
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 6.76
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 6.67
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 6.67
Impact of dieldrin on transcription in Jurkat T cells 6.56
Gene expression in PANC1 cells treated with Rakicidin 6.5
RNA-seq of YB5 cells treated with Proscillaridin A 6.45
Effect of CHKA knockdown on C4-2 cell transcriptome 6.43
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 6.43
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 6.26
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 6.15
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 6.13
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 6.07
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.91
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.91
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.82
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.7
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.67
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.67
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.65
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.65
Lipid degradation promotes prostate cancer cell survival 5.64
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.57
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 5.46
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 5.43
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 5.43
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 5.41
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.4
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 5.38
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 5.38
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 5.31
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 5.11
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 5.09
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 5.04
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 5.01
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 5.01
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.0
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 4.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.96
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.96
EP400 is required for Max and MCPyV mediated gene activation 4.93
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 4.92
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 4.91
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.88
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.86
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.84
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.84
N6-methyladenine DNA Modification in Glioblastoma 4.84
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 4.83
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 4.83
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.82
A549 cell transcriptome responses to infection with H7N9 influenza virus 4.77
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.77
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.76
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.71
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 4.64
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 4.56
Transcriptome profiling of Normal and Cancerous Prostate Cells 4.47
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 4.47
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 4.46
Neurofibroma 4.43
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 4.43
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.41
Lysine benzoylation is a novel histone mark [RNA-seq] 4.41
Lysine benzoylation is a novel histone mark 4.41
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 4.37
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.36
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 4.35
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.33
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 4.31
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 4.31
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 4.3
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 4.28
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 4.28
ARS2 is a general suppressor of pervasive transcription [RNAseq] 4.28
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 4.26
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 4.23
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 4.19
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.19
Differentially expressed genes post knock down of lincDUSP26 4.19
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.17
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 4.14
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 4.13
Regulation of protein translation during mitosis 4.13
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 4.12
R430: A potent inbibitor of DNA and RNA viruses 4.12
Targeting MTHFD2 in Acute Myeloid Leukemia 4.08
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 4.06
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 4.06
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 4.06
Identification of Atrial Fibrillation associated genes and functional non-coding variants 4.0
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 3.96
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 3.96
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 3.9
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 3.81
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.8
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.8
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.78
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.78
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.77
Global gene expression profile of dasatinib-resistant RCH-ACV cells 3.77
RNA-seq of Human neck of femur (NOF) fracture hip and osteoarthritic (OA) cartilage 3.74
Long noncoding RNA ROCR contributes to SOX9 expression and chondrogenic differentiation of human mesenchymal stem cells 3.74
Induced DNA demethylation, genome instability and transcription 3.74
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 3.74
LNCaP treated with iBET 3.73
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 3.73
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 3.71
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 3.71
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 3.7
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.68
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.65
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 3.64
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 3.64
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 3.64
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.62
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 3.61
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 3.61
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.58
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 3.53
RNAseq Study in CC-671 Treated Cal-51 Cells 3.53
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 3.53
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.52
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 3.51
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.47
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 3.45
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 3.43
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 3.42
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 3.42
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 3.42
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 3.42
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 3.39
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 3.37
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 3.37
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 3.36
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.32
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 3.31
Polarized B -cell functions 3.28
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.27
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 3.25
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.22
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.22
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.22
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 3.22
Gene expression profile of human iPSC-derived nephron progenitor cells 3.21
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 3.21
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 3.19
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 3.19
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 3.19
Gene expressions of H9s in different culture systems 3.16
Proliferation-correlated expression 3.16
Dynamic 3D chromosomal landscapes in acute leukemia 3.16
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.16
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 3.16
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 3.15
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 3.15
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 3.14
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 3.14
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 3.14
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.11
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 3.1
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.09
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.07
RNA-seq of tumor cells following angiopellosis extravasation 3.06
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 3.05
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.03
Gene expression analysis in response to hypoxic pathway inhibition 3.02
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.01
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 2.99
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 2.99
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 2.98
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.97
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.97
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 2.97
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 2.97
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 2.96
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.93
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 2.91
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 2.91
Mutational landscape of splicing genes and functional consequences across 33 cancer types 2.91
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 2.89
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 2.89
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 2.89
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 2.88
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.87
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.86
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.85
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 2.84
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 2.81
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 2.81
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.81
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.8
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 2.76
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 2.72
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.7
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 2.7
Gene expression in GBM with Cav3.2 inhibition 2.69
Gene expression profile of human placenta from T. Cruzi infected mothers 2.68
RNA-seq analysis of differentiating human erythroblasts 2.67
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.66
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.66
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.64
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 2.63
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 2.62
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.61
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.61
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.6
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.6
Identification of global XBP1s target gene expression in human prostate cancer cells 2.57
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 2.53
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.52
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 2.51
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 2.51
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 2.51
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 2.49
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 2.49
Effect of PBK knockdown on C4-2 cell transcriptome 2.49
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.49
Androgen Receptor-regulated genes in prostate cancer cells 2.49
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.49
Cerebellar differentiation in Ataxia-Telangiectasia 2.48
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.48
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.46
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.46
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2.45
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 2.44
HEK293 TFAM Knockout Expression Study 2.44
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.42
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.38
MeRIP-seq for heat shock in B-cell lymphoma cells 2.34
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.33
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 2.3
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 2.3
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.3
RNA-Seq with and without RNase treatment in PCa cell lines 2.3
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 2.29
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.28
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 2.27
CDK4/6 inhibitor resistance in prostate cancer 2.24
Total RNA sequencing of APC mutant and wt colonic organoids 2.24
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.24
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.23
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.23
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.23
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 2.22
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 2.21
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 2.21
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.2
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.2
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.2
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.2
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.18
RNA-seq of naive and primed ES cells 2.13
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.13
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.11
Role for citron kinase in prostate cancer growth 2.11
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 2.1
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 2.09
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 2.09
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.08
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 2.06
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.05
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.04
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 2.04
Tracing Enhancer Networks using Epigenetic Traits (TENET) 2.04
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 2.02
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.01
Noncoding regions are the main source of targetable tumor-specific antigens 2.01
Molecular Criteria for Defining the Naive Human Pluripotent State 2.01
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.0
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.0
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 2.0
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 1.98
Global epigenomic reconfiguration during mammalian brain development 1.97
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.96
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 1.96
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 1.93
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 1.93
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.91
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.91
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.91
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.9
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.87
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.86
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 1.85
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 1.85
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.84
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.83
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.78
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.78
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 1.76
The DPYSL2 gene connects mTOR and schizophrenia 1.75
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 1.72
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 1.72
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.7
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.67
Analyses of T-ALL (COG study) 1.67
RNA sequencing of T-ALL (COG study) 1.67
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.67
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 1.63
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 1.61
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.61
Enhancer activation during EGF response 1.61
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.55
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.55
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 1.53
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.53
RNA-seq of naive and primed ES cells (NHSM) 1.52
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.52
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 1.47
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.45
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.44
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 1.43
Targeted enhancer activation by a subunit of the integrator complex 1.39
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.38
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.34
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.33
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 1.32
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.31
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.31
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.28
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 1.27
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.26
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.26
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 1.26
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.24
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.24
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.22
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.21
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.21
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.19
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 1.18
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 1.17
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.17
Transposon-based construction of strand-specific RNA-seq libraries 1.16
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.16
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 1.15
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 1.15
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 1.15
Identification of a LIF-responsive replication-competent human β cell 1.14
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.13
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.13
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.13
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.13
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 1.12
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.11
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.1
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.1
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.1
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.1
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.1
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.08
RNA-seq of SCLC PDX models treated with EP 1.07
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.05
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.04
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.04
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.01
Copper Regulation of HIF-1 Transcription Activity 1.01
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.98
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.94
Real-time observation of light-controlled transcription in living cells 0.9
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.9
iPSC derived motor neuron cultures from C9ORF72 carriers 0.87
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.86
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.83
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.83
Deep RNA sequencing of the human placental transcriptome 0.81
Transcriptome Profiling of Human Primary Monocytes 0.81
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.8
naive T cell heterogeneity after neonatal thymectomy 0.76
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.73
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.73
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.72
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.72
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 0.69
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.67
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.66
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.66
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.61
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.6
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.6
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.6
Transcriptional profile in human S. haematobium infection 0.58
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.57
The circadian transcriptional landscape in primary human mammary epithelial cells 0.57
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 0.56
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.56
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.55
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.55
Epigenomic conservation of transposable element silencing [RNA-seq] 0.55
Epigenomic conservation of transposable element silencing 0.55
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.53
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.52
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 0.51
Age-Related Gene Expression Changes in Prostate Cancer Patients 0.51
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.49
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.48
Functional significance of the HIV-1 Tat signature amino acid residues 0.47
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.46
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.46
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.46
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.46
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.46
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.44
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.43
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.43
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.42
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.41
Transcriptome-wide modulation of splicing by the exon junction complex 0.41
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.4
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.4
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.39
An optimization system for isolating and sequencing of single human colon cancer cells 0.38
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.38
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.37
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.37
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.37
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.37
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.36
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.35
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.32
Leucegene: AML sequencing (part 6) 0.32
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.31
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.29
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.29
Modeling Human Cancer-induced Cachexia (Human) 0.29
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.29
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.29
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.28
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.28
Regulation of poly(A) tail and translation during the somatic cell cycle 0.28
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.27
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.26
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.26
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.23
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.22
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.22
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.22
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.21
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.19
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.15
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.13
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.13
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.11
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.1
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.1
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 0.1
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.09
p53 activity results in DNA replication fork processivity 0.09
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.09
The transcriptome and chromatin accessbility landscape of mammalian germline 0.08
CUREfast: Accelerating research with families 0.07
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.07
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.06
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.05
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.05
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.03
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.03
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation